Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001755283 | SCV002005380 | uncertain significance | not provided | 2019-05-03 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002540613 | SCV003676006 | uncertain significance | Inborn genetic diseases | 2021-11-08 | criteria provided, single submitter | clinical testing | The c.3999C>G (p.I1333M) alteration is located in exon 18 (coding exon 18) of the TG gene. This alteration results from a C to G substitution at nucleotide position 3999, causing the isoleucine (I) at amino acid position 1333 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001755283 | SCV004467770 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001755283 | SCV005196121 | uncertain significance | not provided | criteria provided, single submitter | not provided |